blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1802591

EP1802591 - QUINAZOLINE DERIVATIVES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  16.11.2012
Database last updated on 03.08.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
AstraZeneca AB
151 85 Södertälje / SE
[2007/27]
Inventor(s)01 / PLE, Patrick, AstraZeneca
Reims Z.I. la Pompelle BP 1050
F-51689 Reims, Cedex 2 / FR
02 / JUNG, Frederic Henri, AstraZeneca
Reims Z.I. la Pompelle BP 1050
F-51689 Reims, Cedex 2 / FR
 [2012/02]
Former [2007/27]01 / PLE, Patrick, AstraZeneca
Reims Z.I. la Pompelle BP 1050
F-51689 Reims, Cedex 2 / FR
02 / JUNG, Frederic Henri, AstraZeneca
Reims Z.I. la Pompelle BP 1050
F-51689 Reims, Cedex 2 / FR
Representative(s)(deleted)
[2012/02]
Application number, filing date05789135.007.10.2005
[2007/27]
WO2005GB03846
Priority number, dateEP2004029241712.10.2004         Original published format: EP 04292417
[2007/27]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006040520
Date:20.04.2006
Language:EN
[2006/16]
Type: A1 Application with search report 
No.:EP1802591
Date:04.07.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 20.04.2006 takes the place of the publication of the European patent application.
[2007/27]
Type: B1 Patent specification 
No.:EP1802591
Date:11.01.2012
Language:EN
[2012/02]
Search report(s)International search report - published on:EP20.04.2006
ClassificationIPC:C07D239/88, C07D401/12, C07D403/12, C07D417/12, A61K31/517, A61P35/00
[2007/27]
CPC:
C07D471/04 (EP,KR,US); C07D239/88 (EP,KR,US); A61K31/517 (KR);
A61P1/04 (EP); A61P1/16 (EP); A61P11/00 (EP);
A61P11/06 (EP); A61P13/08 (EP); A61P13/12 (EP);
A61P17/04 (EP); A61P17/06 (EP); A61P19/02 (EP);
A61P19/04 (EP); A61P25/28 (EP); A61P27/02 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P37/08 (EP); A61P43/00 (EP);
A61P5/00 (EP); A61P9/00 (EP); A61P9/10 (EP);
C07D401/12 (EP,KR,US); C07D403/12 (EP,KR,US); C07D413/12 (EP,KR,US);
C07D417/12 (EP,KR,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/27]
Extension statesHR14.05.2007
TitleGerman:CHINAZOLINDERIVATE[2007/27]
English:QUINAZOLINE DERIVATIVES[2007/27]
French:DERIVES DE QUINAZOLINE[2007/27]
Entry into regional phase14.05.2007National basic fee paid 
14.05.2007Designation fee(s) paid 
14.05.2007Examination fee paid 
Examination procedure14.05.2007Examination requested  [2007/27]
20.02.2008Despatch of a communication from the examining division (Time limit: M06)
04.08.2008Reply to a communication from the examining division
27.12.2010Despatch of a communication from the examining division (Time limit: M06)
27.06.2011Reply to a communication from the examining division
09.08.2011Communication of intention to grant the patent
10.11.2011Fee for grant paid
10.11.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.02.2008
Opposition(s)12.10.2012No opposition filed within time limit [2012/51]
Fees paidRenewal fee
31.10.2007Renewal fee patent year 03
28.03.2008Renewal fee patent year 04
02.11.2009Renewal fee patent year 05
02.11.2010Renewal fee patent year 06
31.10.2011Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.10.2005
AT11.01.2012
BE11.01.2012
CY11.01.2012
CZ11.01.2012
DK11.01.2012
EE11.01.2012
FI11.01.2012
LT11.01.2012
LV11.01.2012
PL11.01.2012
RO11.01.2012
SI11.01.2012
SK11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
IE07.10.2012
LU07.10.2012
[2014/34]
Former [2014/27]AT11.01.2012
BE11.01.2012
CY11.01.2012
CZ11.01.2012
DK11.01.2012
EE11.01.2012
FI11.01.2012
LT11.01.2012
LV11.01.2012
PL11.01.2012
RO11.01.2012
SI11.01.2012
SK11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
IE07.10.2012
LU07.10.2012
Former [2013/33]AT11.01.2012
BE11.01.2012
CY11.01.2012
CZ11.01.2012
DK11.01.2012
EE11.01.2012
FI11.01.2012
LT11.01.2012
LV11.01.2012
PL11.01.2012
RO11.01.2012
SI11.01.2012
SK11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
IE07.10.2012
Former [2013/07]AT11.01.2012
BE11.01.2012
CY11.01.2012
CZ11.01.2012
DK11.01.2012
EE11.01.2012
FI11.01.2012
LT11.01.2012
LV11.01.2012
PL11.01.2012
RO11.01.2012
SI11.01.2012
SK11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
Former [2012/50]BE11.01.2012
CY11.01.2012
CZ11.01.2012
DK11.01.2012
EE11.01.2012
FI11.01.2012
LT11.01.2012
LV11.01.2012
PL11.01.2012
RO11.01.2012
SI11.01.2012
SK11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
Former [2012/49]BE11.01.2012
CY11.01.2012
CZ11.01.2012
DK11.01.2012
EE11.01.2012
FI11.01.2012
LT11.01.2012
LV11.01.2012
PL11.01.2012
RO11.01.2012
SI11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
Former [2012/48]BE11.01.2012
CY11.01.2012
EE11.01.2012
FI11.01.2012
LT11.01.2012
LV11.01.2012
PL11.01.2012
SI11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
Former [2012/41]BE11.01.2012
CY11.01.2012
FI11.01.2012
LT11.01.2012
LV11.01.2012
PL11.01.2012
SI11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
Former [2012/39]BE11.01.2012
FI11.01.2012
LT11.01.2012
LV11.01.2012
PL11.01.2012
SI11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
Former [2012/37]BE11.01.2012
FI11.01.2012
LT11.01.2012
PL11.01.2012
SI11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
PT11.05.2012
Former [2012/36]BE11.01.2012
LT11.01.2012
SI11.01.2012
BG11.04.2012
GR12.04.2012
IS11.05.2012
Former [2012/35]BE11.01.2012
LT11.01.2012
SI11.01.2012
BG11.04.2012
IS11.05.2012
Former [2012/34]BE11.01.2012
LT11.01.2012
SI11.01.2012
IS11.05.2012
Former [2012/33]BE11.01.2012
LT11.01.2012
SI11.01.2012
Former [2012/25]SI11.01.2012
Cited inInternational search[DXY]WO9609294  (WELLCOME FOUND [GB], et al) [DX] 1 * page 6, paragraph 3 - page 8, paragraph 5 * [Y] 1-14;
 [DY]WO9615118  (ZENECA LTD [GB], et al) [DY] 1-14 * claim 1 *;
 [DY]WO9703069  (GLAXO GROUP LTD [GB], et al) [DY] 1-14 * page 7, paragraph 1 - page 9, paragraph 4 *;
 [DY]WO0021955  (ZENECA LTD [GB], et al) [DY] 1-14* page 3, line 1 - page 6, line 19 *;
 [DY]WO0121596  (ASTRAZENECA AB [SE], et al) [DY] 1-14 * page 3, line 12 - page 4, line 30; tables 1-14 *;
 [DY]WO0121594  (ASTRAZENECA AB [SE], et al) [DY] 1-14 * page 3, line 7 - page 4, line 28 *;
 [Y]US2003187002  (MORTLOCK ANDREW [GB], et al) [Y] 1-14 * Tables *;
 [DY]WO2004058781  (ASTRAZENECA AB [SE], et al) [DY] 1-14 * page 3, line 28 - page 5, line 14 *;
 [PY]WO2004113324  (ASTRAZENECA AB [SE], et al) [PY] 1-14 * page 3, line 24 - page 6, line 2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.